1. Home
  2. QNCX vs FSHP Comparison

QNCX vs FSHP Comparison

Compare QNCX & FSHP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNCX
  • FSHP
  • Stock Information
  • Founded
  • QNCX 2012
  • FSHP 2018
  • Country
  • QNCX United States
  • FSHP United States
  • Employees
  • QNCX N/A
  • FSHP N/A
  • Industry
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • FSHP
  • Sector
  • QNCX Health Care
  • FSHP
  • Exchange
  • QNCX Nasdaq
  • FSHP NYSE
  • Market Cap
  • QNCX 47.7M
  • FSHP 92.6M
  • IPO Year
  • QNCX 2019
  • FSHP 2024
  • Fundamental
  • Price
  • QNCX $1.73
  • FSHP $10.44
  • Analyst Decision
  • QNCX Strong Buy
  • FSHP
  • Analyst Count
  • QNCX 5
  • FSHP 0
  • Target Price
  • QNCX $8.00
  • FSHP N/A
  • AVG Volume (30 Days)
  • QNCX 294.4K
  • FSHP 918.0
  • Earning Date
  • QNCX 08-12-2025
  • FSHP 01-01-0001
  • Dividend Yield
  • QNCX N/A
  • FSHP N/A
  • EPS Growth
  • QNCX N/A
  • FSHP N/A
  • EPS
  • QNCX N/A
  • FSHP 0.21
  • Revenue
  • QNCX N/A
  • FSHP N/A
  • Revenue This Year
  • QNCX N/A
  • FSHP N/A
  • Revenue Next Year
  • QNCX N/A
  • FSHP N/A
  • P/E Ratio
  • QNCX N/A
  • FSHP $49.08
  • Revenue Growth
  • QNCX N/A
  • FSHP N/A
  • 52 Week Low
  • QNCX $0.51
  • FSHP $9.99
  • 52 Week High
  • QNCX $2.45
  • FSHP $10.48
  • Technical
  • Relative Strength Index (RSI)
  • QNCX 64.55
  • FSHP N/A
  • Support Level
  • QNCX $1.55
  • FSHP N/A
  • Resistance Level
  • QNCX $2.05
  • FSHP N/A
  • Average True Range (ATR)
  • QNCX 0.16
  • FSHP 0.00
  • MACD
  • QNCX 0.01
  • FSHP 0.00
  • Stochastic Oscillator
  • QNCX 49.21
  • FSHP 0.00

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

About FSHP FLAG SHIP ACQUISITION CORPORATION

Flag Ship Acquisition Corp is a blank check company formed to effect a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.

Share on Social Networks: